
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1100 | 1100 | 960 | 641 | 1070 | - |
Fund Return | 10.04% | 10.04% | -4% | -13.76% | 1.35% | - |
Place in category | 81 | 81 | 147 | 109 | 18 | - |
% in Category | 40 | 40 | 82 | 83 | 40 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA SPDB Strategy Em Ind Balance | 708.18M | 0.70 | 3.47 | 8.37 | ||
AXA SPDB Consumption Upgrade Allo A | 586.72M | -5.17 | -0.68 | 4.69 | ||
AXA SPDB Consumption Upgrade Allo C | 586.72M | -5.23 | -0.89 | - | ||
AXA SPDB Growth flexible allocate | 575.6M | -1.48 | -8.47 | -2.39 | ||
AXA SPDB Value Growth Equity A | 521.31M | 0.71 | -9.21 | -2.55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | 2.37 | -15.41 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | 2.17 | -16.08 | - | ||
E Healthcare Secotor | 5.01B | 8.80 | 2.68 | 6.77 | ||
Fullgoal Precision Medical Mix Fund | 4.18B | 15.01 | 0.22 | - | ||
China Universal Healthcare Serv mix | 3.92B | 15.20 | -7.23 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CSPC Innovation | CNE100003K04 | 5.15 | 41.51 | +0.24% | |
WuXi AppTec | CNE1000031K4 | 5.13 | 52.10 | -0.38% | |
Zhejiang Jolly Pharma | CNE100001096 | 4.84 | 16.47 | -0.84% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 4.71 | 105.67 | +1.77% | |
Zhejiang Huahai Pharm | CNE000001DL5 | 4.42 | 14.08 | -0.35% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review